59 results
Page 2 of 3
8-K
EX-99.1
n3z tbosm
27 Apr 21
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
7:10am
424B3
v47fcnj ao
14 Jul 20
Prospectus supplement
4:05pm
8-K
EX-10.4
goeivvha17ns
9 Jan 20
Aravive Announces Management Changes
4:59pm
424B5
asyppl
27 Nov 19
Prospectus supplement for primary offering
4:07pm
424B5
j0hnira
26 Nov 19
Prospectus supplement for primary offering
5:18pm
S-8
EX-99.1
80ydzf
20 Sep 19
Registration of securities for employees
4:09pm
8-K
EX-99.1
sevcahb
8 Aug 19
Aravive Announces Executive Management Transition Plan
5:06pm